Restless legs syndrome induced by escitalopram: Case report and review of the literature

Pharmacotherapy

Volumn 28, Issue 2, 2008, Pages 271-280

  Page II, Robert Lee ^a   Ruscin, J Mark ^a   Bainbridge, Jacquelyn L ^a   Brieke, Andreas A ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Escitalopram; Restless legs syndrome; Serotonin reuptake inhibitors; SNRI; SSRI

Indexed keywords

ANTIDEPRESSANT AGENT; CARVEDILOL; CITALOPRAM; CLONAZEPAM; CYCLOBENZAPRINE; DOBUTAMINE; DOXORUBICIN; ESCITALOPRAM; ESOMEPRAZOLE; FERROUS SULFATE; FLUOXETINE; FUROSEMIDE; HEPARIN; LISINOPRIL; LORAZEPAM; MAGNESIUM DERIVATIVE; MIRTAZAPINE; MULTIVITAMIN; PAROXETINE; POTASSIUM CHLORIDE; PROMETHAZINE; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SPIRONOLACTONE; TORASEMIDE; WARFARIN; ZOLPIDEM;

ADULT; ARTICLE; BEDTIME DOSAGE; CASE REPORT; CONGESTIVE CARDIOMYOPATHY; CREATININE BLOOD LEVEL; DEPRESSION; DIZZINESS; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MORNING DOSAGE; RESTLESS LEGS SYNDROME; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME;

ADULT; CITALOPRAM; DEPRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; RESTLESS LEGS SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 38849100336     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.28.2.271     Document Type: Article

References (49)

1. Picchietti D, Winkelman JW. Restless legs syndrome, periodic limb movements in sleep, and depression. Sleep 2005;28:891-8.
2. Garcia-Borreguero D, Egatz R, Winkelmann J, Berger K. Epidemiology of restless legs syndrome: the current status. Sleep Med Rev 2006;10:153-67.
3. Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med 2003;348:2103-9.
4. Ryan M, Slevin JT. Restless legs syndrome. Am J Health Syst Pharm 2006;63:1599-612.
5. 2 antagonists, restless leg syndrome, and movement disorders. Psychosomatics 1993;34:530-2.
6. Terao T, Terao M, Yoshimura R, Abe K. Restless legs syndrome induced by lithium. Biol Psychiatry 1991;30:1167-70.
7. Wetter TC, Brunner J, Bronisch T. Restless legs syndrome probably induced by risperidone treatment. Pharmacopsychiatry 2002;35:109-11.
8. Kraus T, Schuld A, Pollmacher T. Periodic leg movements in sleep and restless legs syndrome probably caused by olanzapine. J Clin Psychopharmacol 1999;19:478-9.
9. Horiguchi J, Yamashita H, Mizuno S, et al. Nocturnal eating/drinking syndrome and neuroleptic-induced restless legs syndrome. Int Clin Psychopharmacol 1999;14:33-6.
10. Chen JT, Garcia PA, Alldredge BK. Zonisamide-induced restless legs syndrome. Neurology 2003;60:147.
11. Lutz EG. Restless legs, anxiety and caffeinism. J Clin Psychiatry 1978;39:693-8.
12. Aldrich MS, Shipley JE. Alcohol use and periodic limb movements of sleep. Alcohol Clin Exp Res 1993;17:192-6.
13. Lesage S, Hening WA. The restless legs syndrome and periodic limb movement disorder: a review of management. Semin Neurol 2004;24:249-59.
14. Bakshi R. Fluoxetine and restless legs syndrome. J Neurol Sci 1996;142:151-2.
15. Dorsey CM, Lukas SE, Cunningham SL. Fluoxetine-induced sleep disturbance in depressed patients. Neuropsychopharmacology 1996;14:437-42.
16. Prospero-Garcia KA, Torres-Ruiz A, Ramirez-Bermudez J, Velazquez-Moctezuma J, Arana-Lechuga Y, Teran-Perez G. Fluoxetine- mirtazapine interaction may induce restless legs syndrome: report of 3 cases from a clinical trial [letter]. J Clin Psychiatry 2006;67:1820.
17. Agargun MY, Kara H, Ozbek H, Tombul T, Ozer OA. Restless legs syndrome induced by mirtazapine. J Clin Psychiatry 2002;63:1179.
18. Bahk WM, Pae CU, Chae JH, Jun TY, Kim KS. Mirtazapine may have the propensity for developing a restless legs syndrome? A case report. Psychiatry Clin Neurosci 2002;56:209-10.
19. Bonin B, Vandel P, Kantelip JP. Mirtazapine and restless leg syndrome: a case report. Therapie 2000;55:655-6.
20. Chang CC, Shiah IS, Chang HA, Mao WC. Does domperidone potentiate mirtazapine-associated restless legs syndrome? Prog Neuropsychopharmacol Biol Psychiatry 2006;30:316-18.
21. Pae CU, Kim TS, Kim JJ, et al. Re-administration of mirtazapine could overcome previous mirtazapine-associated restless legs syndrome? Psychiatry Clin Neurosci 2004;58:669-70.
22. Hargrave R, Beckley DJ. Restless leg syndrome exacerbated by sertraline. Psychosomatics 1998;39:177-8.
23. Sanz-Fuentenebro FJ, Huidobro A, Tejadas-Rivas A. Restless legs syndrome and paroxetine. Acta Psychiatr Scand 1996;94:482-4.
24. Ozturk O, Eraslan D, Kumral E. Oxcarbazepine treatment for paroxetine-induced restless leg syndrome. Gen Hosp Psychiatry 2006;28:264-5.
25. Perroud N, Lazignac C, Baleydier B, Cicotti A, Maris S, Damsa C. Restless legs syndrome induced by citalopram: a psychiatric emergency? Gen Hosp Psychiatry 2007;29:72-4.
26. Markkula J, Lauerma H. Mirtazapine-induced restless legs. Human Psychopharmacol Clin Exp 1997;12:497-9.
27. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
28. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-19.
29. Hening WA, Allen RP, Earley CJ, Picchietti DL, Silber MH. An update on the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004;27:560-83.
30. Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med 2007;120:S4-12.
31. Trenkwalder C, Paulus W, Walters AS. The restless legs syndrome. Lancet Neurol 2005;4:465-75.
32. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53:547-54.
33. Thorpy MJ. New paradigms in the treatment of restless legs syndrome. Neurology 2005;64:S28-33.
34. Walters AS, LeBrocq C, Dhar A, et al. Validation of the international restless legs syndrome study group rating scale for restless legs syndrome. Sleep Med 2003;4:121-32.
35. Allen RP, Earley CJ. Validation of the Johns Hopkins restless legs severity scale. Sleep Med 2001;2:239-42.
36. Hening WA, Allen RP, Thanner S, et al. The Johns Hopkins telephone diagnostic interview for the restless legs syndrome: preliminary investigation for validation in a multi-center patient and control population. Sleep Med 2003;4:137-41.
37. Connor JR, Boyer PJ, Menzies SL, et al. Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003;61:304-9.
38. Connor JR, Wang XS, Patton SM, et al. Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome. Neurology 2004;62:1563-7.
39. Ondo WG. Restless legs syndrome. Neurol Clin 2005;23:1165-85.
40. Hening WA. Current guidelines and standards of practice for restless legs syndrome. Am J Med 2007;120:S22-7.
41. Silber MH, Ehrenberg BL, Allen RP, et al. An algorithm for the management of restless legs syndrome. Mayo Clin Proc 2004;79:916-22.
42. Zanettini R, Antonini A, Gatto G, Gentile R, Tesei S, Pezzoli G. Valvular heart disease and the use of dopamine agonists for Parkinson's disease. N Engl J Med 2007;356:39-46.
43. Winkelmann J, Prager M, Lieb R, et al. "Anxietas tibiarum": depression and anxiety disorders in patients with restless legs syndrome. J Neurol 2005;252:67-71.
44. Mosko S, Zetin M, Glen S, et al. Self-reported depressive symptomatology, mood ratings, and treatment outcome in sleep disorders patients. J Clin Psychol 1989;45:51-60.
45. Leutgeb U, Martus P. Regular intake of non-opioid analgesics is associated with an increased risk of restless legs syndrome in patients maintained on antidepressants. Eur J Med Res 2002;7:368-78.
46. Dimmitt SB, Riley GJ. Selective serotonin receptor uptake inhibitors can reduce restless legs symptoms [letter]. Arch Intern Med 2000;160:712.
47. Brown LK, Dedrick DL, Doggett JW, Guido PS. Antidepressant medication use and restless legs syndrome in patients presenting with insomnia. Sleep Med 2005;6:443-50.
48. Restless Legs Syndrome Foundation. Special considerations in treating depression when the patient has restless legs syndrome, 2005. Available from http://www.rls.org/NetCommunity/Document.Doc?&id=76. Accessed May 10, 2007.
49. Bedford Laboratories. Dobutrex (dobutamine) package insert. Bedford, OH; 2005.